BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 26600197)

  • 1. MicroRNA-27a-3p Is a Negative Regulator of Lung Fibrosis by Targeting Myofibroblast Differentiation.
    Cui H; Banerjee S; Xie N; Ge J; Liu RM; Matalon S; Thannickal VJ; Liu G
    Am J Respir Cell Mol Biol; 2016 Jun; 54(6):843-52. PubMed ID: 26600197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming growth factor (TGF)-β1-induced miR-133a inhibits myofibroblast differentiation and pulmonary fibrosis.
    Wei P; Xie Y; Abel PW; Huang Y; Ma Q; Li L; Hao J; Wolff DW; Wei T; Tu Y
    Cell Death Dis; 2019 Sep; 10(9):670. PubMed ID: 31511493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-34a Inhibits Lung Fibrosis by Inducing Lung Fibroblast Senescence.
    Cui H; Ge J; Xie N; Banerjee S; Zhou Y; Antony VB; Thannickal VJ; Liu G
    Am J Respir Cell Mol Biol; 2017 Feb; 56(2):168-178. PubMed ID: 27635790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-27a-3p alleviates lung transplantation-induced bronchiolitis obliterans syndrome (BOS) via suppressing Smad-mediated myofibroblast differentiation and TLR4-induced dendritic cells maturation.
    Dong M; Wang X; Li T; Jing Y; Liu Y; Zhao H
    Transpl Immunol; 2023 Jun; 78():101806. PubMed ID: 36925075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-144-3p targets relaxin/insulin-like family peptide receptor 1 (RXFP1) expression in lung fibroblasts from patients with idiopathic pulmonary fibrosis.
    Bahudhanapati H; Tan J; Dutta JA; Strock SB; Sembrat J; Àlvarez D; Rojas M; Jäger B; Prasse A; Zhang Y; Kass DJ
    J Biol Chem; 2019 Mar; 294(13):5008-5022. PubMed ID: 30709904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-145 regulates myofibroblast differentiation and lung fibrosis.
    Yang S; Cui H; Xie N; Icyuz M; Banerjee S; Antony VB; Abraham E; Thannickal VJ; Liu G
    FASEB J; 2013 Jun; 27(6):2382-91. PubMed ID: 23457217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased constitutive αSMA and Smad2/3 expression in idiopathic pulmonary fibrosis myofibroblasts is KCa3.1-dependent.
    Roach KM; Wulff H; Feghali-Bostwick C; Amrani Y; Bradding P
    Respir Res; 2014 Dec; 15(1):155. PubMed ID: 25476248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TGF-β1-induced miR-424 promotes pulmonary myofibroblast differentiation by targeting Slit2 protein expression.
    Huang Y; Xie Y; Abel PW; Wei P; Plowman J; Toews ML; Strah H; Siddique A; Bailey KL; Tu Y
    Biochem Pharmacol; 2020 Oct; 180():114172. PubMed ID: 32712053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Andrographolide ameliorates bleomycin-induced pulmonary fibrosis by suppressing cell proliferation and myofibroblast differentiation of fibroblasts via the TGF-β1-mediated Smad-dependent and -independent pathways.
    Li J; Feng M; Sun R; Li Z; Hu L; Peng G; Xu X; Wang W; Cui F; Yue W; He J; Liu J
    Toxicol Lett; 2020 Mar; 321():103-113. PubMed ID: 31706003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-877-3p targets Smad7 and is associated with myofibroblast differentiation and bleomycin-induced lung fibrosis.
    Wang C; Gu S; Cao H; Li Z; Xiang Z; Hu K; Han X
    Sci Rep; 2016 Jul; 6():30122. PubMed ID: 27444321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential analysis of myofibroblast differentiation and transforming growth factor-β1/Smad pathway activation in murine pulmonary fibrosis.
    Usuki J; Matsuda K; Azuma A; Kudoh S; Gemma A
    J Nippon Med Sch; 2012; 79(1):46-59. PubMed ID: 22398790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis.
    Liu G; Friggeri A; Yang Y; Milosevic J; Ding Q; Thannickal VJ; Kaminski N; Abraham E
    J Exp Med; 2010 Aug; 207(8):1589-97. PubMed ID: 20643828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exosome-Derived microRNA-22 Ameliorates Pulmonary Fibrosis by Regulating Fibroblast-to-Myofibroblast Differentiation in Vitro and in Vivo.
    Kuse N; Kamio K; Azuma A; Matsuda K; Inomata M; Usuki J; Morinaga A; Tanaka T; Kashiwada T; Atsumi K; Hayashi H; Saito Y; Seike M; Gemma A
    J Nippon Med Sch; 2020 Jul; 87(3):118-128. PubMed ID: 31776321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sirtuin 6 inhibits myofibroblast differentiation via inactivating transforming growth factor-β1/Smad2 and nuclear factor-κB signaling pathways in human fetal lung fibroblasts.
    Zhang Q; Tu W; Tian K; Han L; Wang Q; Chen P; Zhou X
    J Cell Biochem; 2019 Jan; 120(1):93-104. PubMed ID: 30230565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-124 regulates transforming growth factor-β1 induced differentiation of lung resident mesenchymal stem cells to myofibroblast by repressing Wnt/β-catenin signaling.
    Lu Y; Zhang T; Shan S; Wang S; Bian W; Ren T; Yang D
    Dev Biol; 2019 May; 449(2):115-121. PubMed ID: 30802451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-323a-3p regulates lung fibrosis by targeting multiple profibrotic pathways.
    Ge L; Habiel DM; Hansbro PM; Kim RY; Gharib SA; Edelman JD; Königshoff M; Parimon T; Brauer R; Huang Y; Allen J; Jiang D; Kurkciyan AA; Mizuno T; Stripp BR; Noble PW; Hogaboam CM; Chen P
    JCI Insight; 2016 Dec; 1(20):e90301. PubMed ID: 27942594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S1PR3 deficiency alleviates radiation-induced pulmonary fibrosis through the regulation of epithelial-mesenchymal transition by targeting miR-495-3p.
    Gong L; Wu X; Li X; Ni X; Gu W; Wang X; Ji H; Hu L; Zhu L
    J Cell Physiol; 2020 Mar; 235(3):2310-2324. PubMed ID: 31489649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lung myofibroblast transition and fibrosis is regulated by circ0044226.
    Zhang L; Chi X; Luo W; Yu S; Zhang J; Guo Y; Ren Q; Zhang W
    Int J Biochem Cell Biol; 2020 Jan; 118():105660. PubMed ID: 31786325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LTBP2 is secreted from lung myofibroblasts and is a potential biomarker for idiopathic pulmonary fibrosis.
    Enomoto Y; Matsushima S; Shibata K; Aoshima Y; Yagi H; Meguro S; Kawasaki H; Kosugi I; Fujisawa T; Enomoto N; Inui N; Nakamura Y; Suda T; Iwashita T
    Clin Sci (Lond); 2018 Jul; 132(14):1565-1580. PubMed ID: 30006483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The antifibrotic effects and mechanisms of microRNA-26a action in idiopathic pulmonary fibrosis.
    Liang H; Xu C; Pan Z; Zhang Y; Xu Z; Chen Y; Li T; Li X; Liu Y; Huangfu L; Lu Y; Zhang Z; Yang B; Gitau S; Lu Y; Shan H; Du Z
    Mol Ther; 2014 Jun; 22(6):1122-1133. PubMed ID: 24594795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.